Anxiang Cai

机构：Shanghai Jiao Tong University, Renji Hospital · ORCID：0000-0002-5480-6582

发表论文 8 篇 · 总被引 210 次 · h-index 6

代表论文

• Angiogenic protein expression in advanced epithelial ovarian cancer. (1997 · PubMed · 被引 102)
• Vascular Permeability: Regulation Pathways and Role in Kidney Diseases (2021 · ˜The œNephron journals/Nephron journals · 被引 32)
• Dapagliflozin alleviates renal inflammation and protects against diabetic kidney diseases, both dependent and independent of blood glucose levels (2023 · Frontiers in Immunology · 被引 23)
• An integrated co-expression network analysis reveals novel genetic biomarkers for immune cell infiltration in chronic kidney disease (2023 · Frontiers in Immunology · 被引 18)
• Genetic inactivation of Semaphorin 3C protects mice from acute kidney injury (2022 · Kidney International · 被引 18)
• Podocyte Pathogenic Bone Morphogenetic Protein‐2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy (2024 · Advanced Science · 被引 15)